HCP Live

Dispensing for the smaller set

Jan 15, 2005

Twenty-five percent of the population in the United States is under the age of 14. What’s more, one-quarter of these children have some type of visual need.

Related Videos

Expanding accessibility of vision correction with spectacles for children with cranial abnormalities

Elkin: Talking about the importance of pediatric eye health and safety

Identifying 3 barriers keeping families from accessing cataract treatment for their children in India

Edward Manche, MD

John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards

rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson

Related Content

FDA-approved drug shows promise in laboratory models for Leber congenital amaurosis type 10

Commercial real estate and your practice, part two with Colin Carr

Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial

March 28th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

MedPAC: Physician payments should be linked to inflation-based index

March 16th 2023

Medicated eye drops may delay myopia in children

March 12th 2023

FDA-approved drug shows promise in laboratory models for Leber congenital amaurosis type 10

Commercial real estate and your practice, part two with Colin Carr

Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial

March 28th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

MedPAC: Physician payments should be linked to inflation-based index

March 16th 2023

Medicated eye drops may delay myopia in children

March 12th 2023

FDA-approved drug shows promise in laboratory models for Leber congenital amaurosis type 10

Commercial real estate and your practice, part two with Colin Carr

Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial

March 28th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

MedPAC: Physician payments should be linked to inflation-based index

March 16th 2023

Medicated eye drops may delay myopia in children

March 12th 2023

Related Content

FDA-approved drug shows promise in laboratory models for Leber congenital amaurosis type 10

FDA-approved drug shows promise in laboratory models for Leber congenital amaurosis type 10

Commercial real estate and your practice, part two with Colin Carr

Commercial real estate and your practice, part two with Colin Carr

Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial

Ocugen announces FDA approval for enrollment of pediatric patients in ongoing OCU400 Phase 1/2 clinical trial

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

MedPAC: Physician payments should be linked to inflation-based index

MedPAC: Physician payments should be linked to inflation-based index

Medicated eye drops may delay myopia in children

Medicated eye drops may delay myopia in children

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.